• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测定局部皮质类固醇致萎缩性的无毛小鼠模型。

The hairless mouse model for assaying the atrophogenicity of topical corticosteroids.

作者信息

Woodbury R, Kligman A M

机构信息

University of Pennsylvania, School of Medicine, Department of Dermatology, Philadelphia 19104-6142.

出版信息

Acta Derm Venereol. 1992 Nov;72(6):403-6.

PMID:1362829
Abstract

The daily application of corticosteroids for 18 days to the dorsal skin of hairless mice resulted in loss of volume of all the cutaneous compartments. The epidermis thinned, sebaceous glands regressed, dermal thickness was reduced, horn-filled cysts shrunk, subcutaneous fat disappeared, and regression of the muscular layer occurred. The magnitude of these changes correlated strongly with the accepted potency ranking of these agents by clinical efficacy. Thus, atrophogenicity predicts anti-inflammatory activity. This model furnishes a simple screening method for assaying corticosteroid activity and for optimizing proprietary formulations.

摘要

在无毛小鼠背部皮肤每日应用皮质类固醇18天,导致所有皮肤层体积减少。表皮变薄,皮脂腺退化,真皮厚度减小,充满角蛋白的囊肿缩小,皮下脂肪消失,肌肉层发生退化。这些变化的程度与这些药物根据临床疗效所公认的效价排名密切相关。因此,致萎缩性可预测抗炎活性。该模型为测定皮质类固醇活性和优化专利配方提供了一种简单的筛选方法。

相似文献

1
The hairless mouse model for assaying the atrophogenicity of topical corticosteroids.用于测定局部皮质类固醇致萎缩性的无毛小鼠模型。
Acta Derm Venereol. 1992 Nov;72(6):403-6.
2
The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids.无毛小鼠作为研究局部外用皮质类固醇后局部和全身萎缩性效应的模型。
Acta Derm Venereol. 1991;71(1):29-31.
3
Dorsal skin reactions of hairless dogs to topical treatment with corticosteroids.无毛犬背部皮肤对皮质类固醇局部治疗的反应。
Toxicol Pathol. 1999 Sep-Oct;27(5):528-35. doi: 10.1177/019262339902700506.
4
Assessment of atrophogenicity of popularly prescribed topical corticosteroids.常用外用皮质类固醇激素萎缩性的评估。
Br J Clin Pract. 1978 Dec;32(12):345-8.
5
Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
Br J Dermatol. 1996 Jul;135(1):60-4.
6
The Duhring chamber assay for corticosteroid atrophy.
Br J Dermatol. 1981 Jan;104(1):57-65. doi: 10.1111/j.1365-2133.1981.tb01712.x.
7
Methods for the assessment of skin atrophogenicity of topical corticosteroids.局部用皮质类固醇皮肤萎缩性评估方法。
Dermatologica. 1976;152 Suppl 1:117-26. doi: 10.1159/000257872.
8
Rapid assay of the anti-inflammatory activity of topical corticosteroids by inhibition of a UVA-induced neutrophil infiltration in hairless mouse skin. I. The assay and its sensitivity.通过抑制无毛小鼠皮肤中紫外线A诱导的中性粒细胞浸润快速测定局部用皮质类固醇的抗炎活性。I. 测定方法及其灵敏度。
Acta Derm Venereol. 1994 Jan;74(1):15-7. doi: 10.2340/00015555741517.
9
Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.鉴定用于测定糖皮质激素受体配体诱导皮肤萎缩的新型体外测试系统。
Skin Pharmacol Physiol. 2010;23(3):139-51. doi: 10.1159/000270386. Epub 2009 Dec 23.
10
Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
J Am Acad Dermatol. 1992 Apr;26(4):535-44. doi: 10.1016/0190-9622(92)70076-r.

引用本文的文献

1
Ghrelin Represses Thymic Stromal Lymphopoietin Gene Expression through Activation of Glucocorticoid Receptor and Protein Kinase C Delta in Inflamed Skin Keratinocytes.胃饥饿素通过激活炎症皮肤角质形成细胞中的糖皮质激素受体和蛋白激酶 C 来抑制胸腺基质淋巴细胞生成素基因的表达。
Int J Mol Sci. 2022 Apr 2;23(7):3977. doi: 10.3390/ijms23073977.
2
cortex inhibits glucocorticoid‑induced bone loss by downregulating Runx2 and BMP‑2 expression.皮质通过下调Runx2和BMP-2的表达来抑制糖皮质激素诱导的骨质流失。
Int J Mol Med. 2021 Aug;48(2). doi: 10.3892/ijmm.2021.4988. Epub 2021 Jun 24.
3
Caffeoyl-Prolyl-Histidine Amide Inhibits Fyn and Alleviates Atopic Dermatitis-Like Phenotypes via Suppression of NF-κB Activation.
咖啡酰基脯氨酰组氨酸酰胺通过抑制 NF-κB 激活抑制 Fyn 并缓解特应性皮炎样表型。
Int J Mol Sci. 2020 Sep 28;21(19):7160. doi: 10.3390/ijms21197160.
4
Sexual dimorphism in atrophic effects of topical glucocorticoids is driven by differential regulation of atrophogene REDD1 in male and female skin.局部糖皮质激素萎缩效应中的性别二态性是由男性和女性皮肤中萎缩基因REDD1的差异调节驱动的。
Oncotarget. 2020 Jan 28;11(4):409-418. doi: 10.18632/oncotarget.27445.
5
PI3K inhibitors protect against glucocorticoid-induced skin atrophy.PI3K 抑制剂可预防糖皮质激素诱导的皮肤萎缩。
EBioMedicine. 2019 Mar;41:526-537. doi: 10.1016/j.ebiom.2019.01.055. Epub 2019 Feb 5.
6
Chaperoning skin atrophy.陪伴皮肤萎缩。
Oncotarget. 2018 Nov 23;9(92):36407-36408. doi: 10.18632/oncotarget.26375.
7
Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy.雷帕霉素调节糖皮质激素受体功能,阻断萎缩基因 REDD1,并保护皮肤免受类固醇萎缩。
J Invest Dermatol. 2018 Sep;138(9):1935-1944. doi: 10.1016/j.jid.2018.02.045. Epub 2018 Mar 27.
8
Longitudinal in vivo tracking of adverse effects following topical steroid treatment.局部类固醇治疗后不良反应的纵向体内追踪
Exp Dermatol. 2016 May;25(5):362-7. doi: 10.1111/exd.12932. Epub 2016 Feb 13.
9
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin.糖皮质激素受体化合物A的选择性激活剂可分离皮肤中糖皮质激素受体信号的治疗作用和致萎缩作用。
J Cancer Prev. 2015 Dec;20(4):250-9. doi: 10.15430/JCP.2015.20.4.250. Epub 2015 Dec 30.
10
REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids.REDD1在局部糖皮质激素的治疗作用和不良反应之间的交叉点发挥作用。
EMBO Mol Med. 2015 Jan;7(1):42-58. doi: 10.15252/emmm.201404601.